Skip to main content

CITIGROUP INC

Position in CCCC — C4 Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in CCCC

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$230,645
+$119,060 QoQ
Shares Held
49,389
+16.4% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 147 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CCCC Over Time

Shares Held

Position Value (USD)

Derivatives in CCCC

reported options exposure · as of Dec 31, 2024
CallValue
$519,480
CallShares
144,300
PutValue
$41,760
PutShares
11,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $2,077,377,990 across 384 Biotechnology names. CCCC ranks #203 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CCCC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $230,645 49,389
2026-03-31 $111,585 42,428
2025-12-31 $95,194 49,840
2025-09-30 $7,245 3,264
2025-06-30 $32,626 22,816
2025-03-31 $69,431 43,395
2024-12-31 $519,480 144,300
2024-12-31 $41,760 11,600
2024-12-31 $210,152 58,376
2024-09-30 $592,617 103,968
2024-09-30 $142,500 25,000
2024-06-30 $140,706 30,456
2024-03-31 $6,296,846 770,728
2023-12-31 $765,422 135,473
2023-09-30 $107,682 57,894
2023-06-30 $50,605 18,402
2023-03-31 $4,455 1,419
2022-12-31 $464,961 78,807
2022-09-30 $912,807 104,083
2022-06-30 $35,421 4,698
2022-03-31 $577,823 23,818
2021-12-31 $2,655,727 82,476
2021-09-30 $2,983,015 66,764
2021-06-30 $2,856,617 75,492
2021-03-31 $2,130,771 57,604
2020-12-31 $66,922 2,020